Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Biodel's VIAject ultra rapid acting insulin

Thanks for your fast reply. Also on their web-site, on the same page they talk about BIOD-123 and BIOD-125, which seem to have more promise of being viable.

In the Phase 1 clinical trial, absorption rates of BIOD-123 and BIOD-125 were significantly faster than that of Humalog® as indicated by 64% and 54% reductions, respectively, in mean times to half maximal insulin concentrations (p < 0.001 for both BIOD-123 and BIOD-125 compared to Humalog®). Both RHI-based formulations and Humalog®were well tolerated, with injection site tolerability generally perceived by patients to be similar to that of their usual mealtime injections used at home.

Share
New Message
Please login to post a reply